How to inject tirzepatide 2.5 mg: a step-by-step technique guide

What the official guidance says about starting at 2.5 mg

The Mounjaro SmPC (the authoritative prescribing document published on the Electronic Medicines Compendium) establishes 2.5 mg as the dose used in weeks one to four of treatment. Its role is tolerability, giving your gut hormone receptors time to adapt to a dual GIP and GLP-1 stimulus before the dose is reviewed. This isn't unique to tirzepatide: the same step-wise principle runs through the SURMOUNT clinical programme, where participants began at this dose before titrating upward at four-week intervals under medical supervision. The result was an average body-weight reduction of around 20–21% at the 15 mg maintenance dose over 72 weeks, but that trajectory starts here, with the first 2.5 mg injection done correctly.

What this means practically is that you shouldn't expect dramatic effects in the first four weeks, and that's by design. The 2.5 mg pen is not a smaller version of the therapeutic dose; it is a distinct, deliberate starting point. Detailed information on what to expect from the 2.5 mg injection can help set realistic expectations before you begin. Your prescriber decides whether and when titration to the 5 mg tirzepatide injection is appropriate, and that decision is not something to pre-empt.

Preparing your pen: the steps that matter most before you inject

Take the pen out of the fridge roughly thirty minutes before you plan to inject, room-temperature medicine tends to be more comfortable going in. While it's warming, wash your hands thoroughly with soap and water and dry them completely. You'll also need a new needle (not supplied with the pen, attached immediately before use) and your sharps container within reach.

Check the pen label to confirm it's the 2.5 mg strength, then inspect the viewing window. The liquid should be clear or very slightly yellow and free of visible particles. If it looks cloudy, discoloured or contains floating material, don't use it, contact your pharmacy. Remove the base cap, attach the needle by pressing it straight onto the pen and twisting until it's secure, then remove both the outer needle cap and the inner one. You don't need to prime or purge the pen; it arrives ready to dose. A fresh alcohol swab at the injection site is optional but can help reduce surface bacteria, a small detail that's easy to build into your routine. For more on Mounjaro injection technique in general, that page covers the process across strengths.

How to inject 2.5 mg of tirzepatide: the injection itself

Pinch a small fold of skin at your chosen site (abdomen (at least 5 cm from the navel), outer thigh, or upper arm) or simply hold the area flat if you find that easier. Press the pen firmly and flatly against the skin at a right angle; the device is designed for 90-degree insertion. Press the purple injection button with your thumb and hold it down. You'll hear a click at the start. Keep the button held and count a slow ten seconds; this ensures the full 2.5 mg dose is delivered. A second click during that window is normal. When you release and pull the pen away, check that the grey plunger in the viewing window has moved, that's your confirmation the dose went in.

Don't rub the site afterwards. If there's a small dot of blood, gentle pressure with a clean cotton pad is fine. Remove the needle immediately, replace the outer needle cap one-handed by scooping it on a flat surface (not by holding the cap), unscrew the needle and place it directly into your sharps container. The pen itself goes into household rubbish once the needle is off. People starting on the 2.5 mg dose sometimes worry they've done something wrong when they see very little at the injection site, the volume is small, and that's correct.

Site rotation and what to do if something doesn't feel right

Rotating your injection site each week isn't a minor administrative detail, it genuinely matters. Injecting repeatedly into the same spot can cause lipohypertrophy, a thickening of subcutaneous tissue that slows absorption and makes subsequent injections less predictable. A simple way to manage this is to divide each site into zones and move clockwise around them. You can also alternate between body areas entirely: abdomen one week, thigh the next, upper arm the week after.

Mild redness, itching or a small lump at the site in the hours after injection is common and usually resolves within a day. Nausea in the first couple of days after your initial 2.5 mg dose is among the most frequently reported experiences; it tends to ease as your body adjusts. However, certain symptoms need prompt medical attention: severe or persistent stomach pain that extends to your back, signs of an allergic reaction such as swelling of the face or difficulty breathing, or any symptom that worries you. The MHRA Yellow Card scheme lets you report unexpected side effects directly and contributes to ongoing safety monitoring of medicines like tirzepatide.

If your question is about what happens when your prescriber considers moving you from 2.5 mg to the next strength, the page on injecting 2.5 mg from the 5 mg pen addresses that specific transition. And if you'd like a broader sense of how tirzepatide fits into a weight-management plan, our full Mounjaro guide covers the evidence, the process and the practicalities in one place. When you're ready to talk to a prescriber about starting treatment, speak to our prescribers through a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber, not software.